Cancer Imaging

INSTRUMENTATION AND GENERAL APPLICATIONS <br><br>CHAPTER 1. INTRODUCTION<br><br>CHAPTER 2. MULTIDETECTOR-ROW COMPUTED TOMOGRAPHY SCANNING: PROJECTED RISKS <br><br>CHAPTER 3. POSITRON EMISSION TOMOGRAPHY SCANNING AND FUNCTIONAL ANATOMIC IMAGE FUSION <br><br>CHAPTER 4. SINGLE - PHOTON EMISSION COMPUTED TOMOGRAPHY <br><br>CHAPTER 5. DYNAMIC INFRARED IMAGING <br><br>CHAPTER 6. IN VIVO BROADBAND SPECTROSCOPY <br><br>CHAPTER 7. MAGNETIC RESONANCE SPECTROSCOPIC IMAGING <br><br>CHAPTER 8. COMBINED Tl-WEIGHTED DYNAMIC CONSTANT AGENT-ENHANCED MAGNETIC RESONANCE IMAGING, HYDROGEN 1 MAGNETIC RESONANCE SPECTROSCOPY, AND PERFUSION MAGNETIC RESONANCE IMAGING <br><br>CHAPTER 9. ULTRASOUND IMAGING <br><br>CHAPTER 10. ROLE OF ULTRASOUND IN MOLECULAR IMAGING <br><br>CHAPTER 11. WHOLE - BODY COMPUTED TOMOGRAPHY SCREENING <br><br>CHAPTER 12. POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY WHOLE - BODY IMAGING <br><br>CHAPTER 13. RADIATION DOSE IN COMPUTED TOMOGRAPHY <br><br>CHAPTER 14. RISK OF CANCER FROM DIAGNOSTIC X-RAYS<br><br>CHAPTER 15. LEGAL AND ETHICAL ISSUES IN RADIOLOGIC SCREENING <br><br>CHAPTER 16. NEAR-INFRARED OPTICAL IMAGING OF PROTEASES IN CANCER <br><br>CANCERS <br><br>CHAPTER 17. ANTI-HER-2 ANTIBODY AS AN ANTITUMOR AGENT <br><br>CHAPTER 18. IMAGING TO DETECT RECURRENT CANCER <br><br>CHAPTER 19. ANTIBODY IMAGING AND THERAPY OF CANCER <br><br>CHAPTER 20. MOVEMENT OF INVASIVE TUMOR CELLS: INTRAVITAL IMAGING <br><br>CHAPTER 21. METASTASES: WHOLE - BODY MAGNETIC RESONANCE IMAGING <br><br>CHAPTER 22. SOLID TUMORS: FUSED POSITRON EMISSION TOMOGRAPHY ICOMPUTED TOMOGRAPHY <br><br>CHAPTER 23. INTRAOPERATIVE MAGNETIC RESONANCE IMAGING <br><br>CHAPTER 24. PELVIC IMAGING: SINGLE - PROTON EMISSION COMPUTED TOMOGRAPHY <br><br>CHAPTER 25. IMAGING TECHNOLOGY IN ANTICANCER EFFICACY EVALUATIONS <br><br>CHAPTER 26. IMAGE-GUIDED CANCER THERAPY USING POSITRON EMISSION TOMOGRAPHY/COMPUTED TOMOGRAPHY <br><br>CHAPTER 27. ONCOLOGICAL MOLECULAR IMAGING<br><br>CHAPTER 28. DIAGNOSTIC IMAGING OF CANCER: RADIOPHARMACEUTICALS <br><br>CHAPTER 29. ADRENAL TUMORS: CURRENT VIEWS ON IMAGING<br><br>ANGIOGRAPHY <br><br>CHAPTER 30. COMPUTED TOMOGRAPH ANGIOGRAPHY <br><br>CHAPTER 31. MAGNETIC RESONANCE ANGIOGRAPHY WITH PARALLEL IMAGING <br><br>BREAST CANCER <br><br>CHAPTER 32. DYNAMIC BREAST MAGNETIC RESONANCE IMAGING <br><br>CHAPTER 33. SINGLE-PROTON EMISSION COMPUTED TOMOGRAPHY FOR EVALUATING AXILLARY LYMPH NODE STATUS IN BREAST CANCER PATIENTS<br><br>CHAPTER 34. POSITRON EMISSION TOMOGRAPHY OF PATIENTS WITH A LOCOREGIONALL Y RECURRENCE OF BREAST CANCER <br><br>CHAPTER 35. MAGNETIC RESONANCE IMAGING OF INVASIVE LOBULAR CARCINOMA<br><br>CHAPTER 36. IMAGING OF MICROCIRCULATION AND MICROVASCULATURE IN BREAST CANCER: DYNAMIC MAGNETIC RESONANCE <br><br>CHAPTER 37. MAMMOGRAMS: COMPUTER-AIDED DETECTION WITH DOUBLE READING <br><br>CHAPTER 38. DETECTION OF DISTANT RECURRENCE OF BREAST CANCER BY MAMMOGRAPHY SCREENING<br><br>CHAPTER 39. BREAST ULTRASOUND EXAMINATION <br><br>CHAPTER 40. AXILLARY LYMPH NODE STATUS: SINGLE - PHOTON EMISSION COMPUTED TOMOGRAPHY<br><br>CHAPTER 41: DYNAMIC CONTRAST-ENHANCED MAGNETIC RESONANCE I IMAGING<br><br>LUNG CANCER <br><br>CHAPTER 42. POSITRON EMISSION TOMOGRAPHY AND FUNCTIONAL ANATOMIC FUSION IMAGING IN LUNG AND BREAST CANCERS<br><br>CHAPTER 43. DIFFERENTIATED THYROID CARCINOMA LUNG METASTASES: RADIOIODINE THERAPY IMAGING<br><br>CHAPTER 44. NONS MALL CELL LUNG CARCINOMA: STEREOTACTIC IRRADIATION-COMPUTED TOMOGRAPHY<br><br>CHAPTER 45. NONSMALL CELL LUNG CARCINOMA: 18F_ FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY <br><br>CHAPTER 46. COMPUTED TOMOGRAPHY <br><br>CHAPTER 47. TREATMENT OF NON-SMALL-CELL LUNG CANCER <br><br>CHAPTER 48. LUNG METASTASES OF THYROID CANCER: WHOLE - BODY SCINTIGRAM <br><br>CHAPTER 49. RETINOBLASTOMA: COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING <br><br>CHAPTER 50. RENAL CANCER: MAGNETIC RESONANCE IMAGING<br><br>CHAPTER 51. LUNG TUMORS: 3 DEOXY-3-[18F] FLUOROTHYMIDINE-POSITRON EMISSION TOMOGRAPHY<br><br>LIVER CANCER <br><br>CHAPTER 52. HARMONIC IMAGING OF FOCAL LIVER LESIONS <br><br>CHAPTER 53. IMAGING OF THE LIVER BY HELICAL COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE<br><br>CHAPTER 54. HEPATOCELLULAR CANCER: MAGNETIC RESONANCE IMAGING<br><br>CHAPTER 55. HEPATOCELLULAR CARCINOMA AND ADENOMATOUS HYPERPLASIA: DYNAMIC COMPUTED TOMOGRAPHY AND A COMBINATION OF COMPUTED TOMOGRAPHY AND ANGIOGRAPHY <br><br>CHAPTER 56. DIAGNOSIS OF HEPATOCELLULAR CARCINOMA: MULTIDETECTOR ROW COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING <br><br>CHAPTER 57. RADIOLOGICAL IMAGING OF HEPATOCELLULAR CARCINOMA IN CIRRHOTIC PATIENTS<br><br>CHAPTER 58. AFFERENT AND EFFERENT VESSELS OF PREMALIGNANT AND OVERT HEPATOCELLULAR CARCINOMA: COLOR DOPLER IMAGING<br><br>CHAPTER 59. CONTRAST-ENHANCED SONOGRAPHY FOR HEPATOCELLULAR CARCINOMA <br><br>CHAPTER 60. INTRATUMORAL VASCULARITY IN SMALL HEP ATOCELLULAR CARCINOMA: CODED PHASE INVERSION HARMONICS<br><br>CHAPTER 61. HEPATOCELLULAR CARCINOMA WITH NODULE-IN-NODULE APPEARANCE: CONTRAST-ENHANCED CODED PHASE INVERSION HARMONIC IMAGING<br><br>CHAPTER 62. IMAGING OF DYSPLASTIC NODULES AND SMALL HEP ATOCELLULAR CARCINOMAS<br><br>CHAPTER 63. AFFERENT AND EFFERENT VESSELS OF PREMALIGNANT AND OVERT HEPATOCELLULAR CARCINOMA: COLOR DOPLER IMAGING<br><br>CHAPTER 64. ASSESSMENT OF HEPATOCELLULAR CARCINOMA: CONTRAST -ENHANCED PERFUSIONAL SONOGRAPHY<br><br>CHAPTER 65. DEPICTION OF HEPATOCELLULAR CARCINOMA: DYNAMIC STEADY STATE FREE PRECESSION MAGNETIC RESONANCE IMAGING<br><br>CHAPTER 66. IMAGING DIAGNOSIS OF CIRRHOSIS AND CHRONIC HAPATITIS<br>Dr. K. Ito, Yamaguchi University, Department of Radiology, School of Medicine, Yamaguchi, Japan<br><br>CHAPTER 67. DIFFERENTIATION OF HEPATIC TUMORS: COLOR DOPLER IMAGING<br><br>CHAPTER 68. METASTASIS OF HEPATOCELLULAR CARCINOMA TO THE HEART: MAGNETIC RESONANCE IMAGING<br><br>CHAPTER 69. LIVER METASTASES FROM COLORECTAL CANCER: ULTRASOUND IMAGING OF FLOW PATTERNS <br><br>CHAPTER 70. HEPATIC COLORECTAL METASTASES DETECTION BEFORE RESECTONING: 18F-FLUORODEOXYGLUCOSE- POSITRON EMISSION TOMOGRAPHY SCANNING<br><br>CHAPTER 71. CONTRAST-ENHANCEDSONOGRAPHYFOR HEP ATOCELLULAR CARCINOMA <br>PROSTATE CANCER <br>CHAPTER 72. FAST ACQUISITION-WEIGHTED THREE-DIMENSIONAL PROTON MAGNETIC RESONANCE SPECTROSCOPY IMAGING<br><br>CHAPTER 73. CHRONIC PROSTATITIS: THREE DIMENSIONAL PROTON MAGNETIC RESONANCE SPECTROSCOPIC IMAGING<br><br>CHAPTER 74. RECURRENT PROSTATE CANCER: MAGNETIC RESONANCE IMAGING OR COMPUTED TOMOGRAPHY IN PATIENTS<br><br>CHAPTER 75. PROTON MAGENTIC RESONANCE SPECTROSCOPIC IMAGING <br><br>CHAPTER 76. SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY<br><br>CERVICAL CANCER <br><br>CHAPTER 77. CERVICAL INTRAEPITHELIAL NEOPLASIA: DOUBLE RATIO FLUORESCENCE IMAGING<br><br>CHAPTER 78. RECURRENT CERVICAL CANCER: 18F_ FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHY<br><br>CHAPTER 79. UTERINE CERVICAL CARCINOMA: PREOPERATIVE MAGNETIC RESONANCE IMAGING STAGING<br><br>BRAIN CANCER <br><br>CHAPTER 80. NEUROBLASTOMA: COMPUTED TOMOGRAPHY<br><br>CHPATER 81. NEUROENDOCRINE TUMORS: 618p-FLUORODOPA-POSITRON EMISSION TOMOGRAPHY<br><br>CHAPTER 82. BRAIN TUMORS: IMAGING OF IRON OXIDE WITH MAGNETIC RESONANCE IMAGING<br><br>CHAPTER 83. 18F-FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHY<br><br>CHAPTER 84. COMPARISON OF 18F-FLUORODEOXYGLUCOSE AND "C-METHIONINE FOR POSITRON EMISSION - GUIDED STEREOTACTIC IMAGING<br><br>CHAPTER 85. GLIOMA: TEMOZOLOMIDE TREATMENT AND MAGNETIC RESONANCE IMAGING<br>Hanna O. Maenpaa, Department of Oncology, Helsinki University Central Hospital, Finland<br><br>CHAPTER 86. DIFFUSION TENSOR IMAGING OF BRAIN TUMORS<br><br>CHAPTER 87. IMAGING ENDOGENOUS GENE EXPRESSION IN BRAIN CANCER<br><br>GASTROINTESTINAL CANCER<br><br>CHAPTER 88. RESISTANCE TO IMATINIB THERAPY IN A METASTATIC GASTROINTESTINAL STROMAL TUMOR: COMPUTED TOMOGRAPHY<br><br>CHAPTER 89. IMAGING OF GASTROINTESTINAL STROMAL TUMORS<br><br>CHAPTER 90. ANTIANGIOGENIC THERAPY FOR GASTROINTESTINAL TUMORS<br><br>CHAPTER 91. TREATMENT OF INTESTINAL TUMORS WITH AGMATINE<br><br>CHAPTER 92. TREATMENT OF GASTROINTESTINAL CANCER WITH CAPECIT ABINETMITOMYCIN C<br><br>CHAPTER 93. ADJUVANT ORAL TAGAFUR TREATMENT FOR GASTRIC CANCER PATIENTS <br><br>CHAPTER 94. TREATMENT OF INOPERABLE GASTRIC CANCER: COMPARISON BETWEEN MITOMYCIN-CISPLA TIN - DOXIFLURIDINE AND CISPLATIN-DOXIFLURIDINE<br><br>CHAPTER 95. CLINICAL RESPONSE OF METASTATIC GASTRIC CANCER TO 5-DEOXY-5-FLUOROURIDINE?<br><br>CHAPTER 96. CHEMOSENSITIVITY OF GASTRIC CANCER TO 5-FLUOROURACIL<br><br>CHAPTER 97. IN VIVO DETECTION BY ELECTRON PARAMAGNETIC RESONANCE IMAGING<br><br>CHAPTER 98. GASTROINTESTINAL STROMAL TUMORS OF THE STOMACH: COMPUTED TOMOGRAPHY <br><br>CHAPTER 99. GASTRIC MOTILITY DISORDERS: REAL TIME MAGNETIC RESONANCE IMAGING<br><br>CHAPTER 100. HAND-ASSISTED LAPROSCOPIC SURGERY FOR ADVANCED-STAGE PROXIMAL GASTRIC CANCER<br><br>CHAPTER 101. EARLY GASTRIC CANCER: NARROW BAND IMAGING<br><br>CHAPTER 102. EARLY GASTRIC CANCER: MAGNIFYING ENDOSCOPY<br><br>OVARIAN CANCER<br><br>CHAPTER 103. ADVANCED OVARIAN CARCINOMA: COMPUTED TOMOGRAPHY<br><br>CHAPTER 104. PREDICTING SUBOPTIMAL CYTOREDUCTIVE SURGERY IN ADVANCED OVARIAN CARCINOMA: COMPUTED TOMOGRAPHY SCANNING<br><br>CHAPTER 105. TREATMENT OF OVARIAN CANCER WITH CARBOPLATIN FOLLOWED BY PACLIT AXEL AND GEMCIT ABIN<br><br>CHAPTER 106. SYNERGIC EFFECT OF SU5416 AND CISPLATIN IN CYTOTOXICITY IN OVARIAN TUMOR CELLS<br><br>CHAPTER 107. OVARIAN CHORIOCARCINOMA: COMPUTED TOMOGRAPHY, MAGNETIC RESONANCE IMAGING AND SONOGRAPHY<br><br>CHAPTER 108. COLOR DOPPLER ULTRASOUND EXAMINATION<br><br>COLORECTAL CANCER<br><br>CHAPTER 109. COLON CANCER: 18F-FLUORODEOXYGLUCOSE-POSITRON EMISSION TOMOGRAPHY<br><br>CHAPTER 110. EARLY COLON CANCER DETECTOIN: 18F_ FLUORODEOXYGLUCOSE POSITRON EMISSION TOMOGRAPHY<br><br>CHAPTER 111. COMPUTED TOMOGRAPHIC COLONOGRAPHY WITH COMPUTER - AIDED DETECTION<br><br>CHAPTER 112. FUNCTIONAL IMAGING OF COLORECTAL AND ESOPHAGEAL CANCER: POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY<br><br>CHAPTER 113. METASTATIC COLORECTAL CANCER: 18F_ FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHY<br><br>CHAPTER 114. COMPUTED TOMOGRAPHIC COLONOGRAPHY <br><br>CHAPTER 115. LAXATIVE-FREE COLONOGRAPHY: COMPUTED TOMOGRAPHY<br><br>GALLBLADDER CANCER <br><br>CHAPTER 116. 18F-FLUORODEOXYGLUCOSE - POSITRON EMISSION TOMOGRAPHY<br><br>ESOPHAGEAL CANCER <br><br>CHAPTER 117. POSITRON EMISSION TOMOGRAPHY/COMPUTERIZED TOMOGRAPHY FUNCTIONAL IMAGING<br><br>HEAD AND NECK CANCER <br><br>CHAPTER 118. HEAD AND NECK SQUAMOUS CELL CARCINOMA: IMAGING WITH RADIATION DOSIMETRY OF 99m Tc-LABELED C 225<br><br>BRONCHIAL CANCER<br><br>CHAPTER 119. AUTOFLUORESCENCE SPECTROSCOPY-DIFFUSE REFLECTANCE SPECTROSCOPY<br><br>BONE CANCER <br><br>CHAPTER 120. BONE AND SOFT TISSUE TUMORS: IN VIVO IH MAGNETIC RESONANCE SPECTROSCOPY <br><br>METASTATIC MEDULLARY THYROID CANCER <br><br>CHAPTER 121. IlI In - DTP A - octreotide and 131 I/123I - MIBG<br><br>CHAPTER 122. THYROID NEOPLASMS: THREE - DIMENSIONAL RECONSTRUCTION OF ANGIOARCHITECTURE<br><br>CHAPTER 123. ANAPLASTIC THYROID CANCER: MULTIMODALITY IMAGING <br>PANCREATIC DUCTAL ADENOCANCER: <br>CHAPTER 124. ULTRASONOGRAPHY<br><br>LYMPHOMA <br>CHAPTER 125. LYMPHOMA: POSITRON EMISSION TOMOGRAPHY<br><br>CHAPTER 126. NON-HODGKIN'S LYMPHOMA: COMPUTED TOMOGRAPHY AND MAGNETIC RESONANCE IMAGING <br><br>MELANOMA LESIONS <br><br>CHAPTER 127. MELANOMA LESSIONS: 99m Tc - INTERLEUKIN - 2 SCINTIGRAPHY<br><br>MULTIPLE MYELOMA <br><br>CHAPTER 128. COMPUTED TOMOGRAPHY